跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13 条关于
“PrecivityAD”
全部
13
临床试验
2
药物
0
机构
0
资讯
11
上个月
FDA Clears C2N Diagnostics' PrecivityAD2 Blood Test for Alzheimer's in Adults as Young as 40
去年
Blood Tests Offer Hope for Earlier, Easier Alzheimer's Diagnosis
3个月前
CTAD and ADDF Join Forces to Launch Biotech Showcase at CTAD 2026, Aiming to Accelerate Next-Generation Alzheimer's Therapies
6个月前
MindImmune Secures $5 Million ADDF Investment to Advance First-in-Class Alzheimer's Immunotherapy MITI-101
11个月前
ADDF Releases SpeechDx Dataset to Advance AI-Powered Alzheimer's Detection Through Speech Biomarkers
去年
ADDF Invests $2.16 Million in Life Molecular Imaging's Novel PET Tracer for Alzheimer's Neuroinflammation
去年
Circular Genomics Secures $250K ADDF Investment to Advance CircRNA Blood Biomarkers for Alzheimer's Diagnosis
去年
PrecivityAD2 Blood Test Enhances Alzheimer's Diagnosis and Treatment Decisions
去年
Splash Clinical and C2N Diagnostics Partner to Revolutionize Alzheimer's Trial Recruitment with Blood-Based Biomarkers
6个月前
C2N Diagnostics Expands Alzheimer's Blood Test Access Across Asia Through Strategic Partnerships
第 1 页,共 2 页
上一页
下一页